Follicum April 2019 BioStock Presentation
May 28, 2019 /
CEO of Follicum, Jan Alenfall, recently presented his company at the BioStock meeting which took place on April 29, 2019 in Stockholm, Sweden.
The presentation details Follicum’s successes and plans for its diabetes and hair growth programs. Follicum’s hair growth program is composed of its peptide drug called FOL-005.The section discussing the hair growth program begins at about 7:25 in the video. During the presentation, Alenfall speaks about:
- How FOL-005 compares to minoxidil in a clinical trial
- How FOL-005 compares to finasteride in a clinical trial
- The development of a topical formulation of FOL-005
- Planning a four month study of a topical formula of FOL-005
At around the 18:00 minute mark towards the end of the presentation, Alenfall answers more direct questions from the audience about the effects of FOL-005 to regrow hair.
Posted in Follicum
Will the hair loss continue after a course of treatment, such as longevity, such as Minoxidil?
What are the side effects?
What is the effectiveness of baldness treatment for men?
The video discusses the effectiveness. No side effects known now, but it’s still early. Too soon to also know if you need to continue to apply this like minoxidil, but presumably you would need to continue to apply this.
This people only do money on this trials and studies. They do not know how to do products or cure the problem, research is research.